Previous studies have shown that disruption of the neuronal cytoskeleton, which normally functions to maintain cytoplasmic compartmentalization, intracellular transport and neuronal morphology, is a key feature of Alzheimer's disease. Paired helical filaments, the primary ultrastructural constituent of neurofibrillary tangles, contain the microtubule associated [protein, tan, as an integral component. Tau and other cytoskeletal proteins are reorganized in Alzheimer's disease, thereby providing potential substrate for widespread degeneration and growth response. Our hypothesis is that degeneration and regeneration are critically dependent on cytoskeletal composition. A major goal of the present study is to establish the precise morphology and distribution of the microtubule-associated proteins MAP2 and tau, and the protein ubiquitin in the medical temporal lobe and their relationship to neurofibrillary tangles, as defined by thioflavine S and Hicks-Gallyas staining, in aged controls and Alzheimer's disease patients. The medical temporal lobe encompasses a range of cortical and subcortical regions fundamental to memory processing which are lesioned in Alzheimer's disease. We will define distribution of tau isoforms because alterations of tau may be important in the formation of paired helical filaments. Differentially affected regions will be examined in patients with Alzheimer's disease of variable severity, duration, and age of onset to determine the chronology of alterations. The distribution of kinases potentially responsible for phosphorylation of tau, such as CaM kinase type II, will be defined. The nature and extent of growth response in Alzheimer's disease will be examined using markers associated with growth cones, including actin, GAP 43, and neural cell adhesion molecule. Specific procedures include immunoperoxidase, immunofluorescence, and immunogold procedures using well characterized antisera. Colocalization studies to determine the interrelationship of cytoskeletal proteins will be performed using double immunofluorescence and immunoperoxidase procedures.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005134-10
Application #
3768049
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
10
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Wegmann, Susanne; Eftekharzadeh, Bahareh; Tepper, Katharina et al. (2018) Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J 37:
Racine, Annie M; Brickhouse, Michael; Wolk, David A et al. (2018) The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimers Dement (Amst) 10:301-310
Bennett, Rachel E; Robbins, Ashley B; Hu, Miwei et al. (2018) Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease. Proc Natl Acad Sci U S A 115:E1289-E1298
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 966 publications